GoodRx Holdings Inc. (GDRX) Latest News and Helpful Information

How have the shares performed?


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



GoodRx Holdings Inc. (GDRX) saw downtrend of -2.90% in the recent trading with $38.85 being its most recent. The current price level -39.50% lower than the highest price of $64.22 marked by the stock while trading over the past 52-weeks, whereas it is 16.35% higher than the lowest price of $33.39 the company dropped to over past 52-weeks. The latest news story on GDRX appeared in Zacks under the title “Zacks Industry Outlook Highlights: Avantor, Eurofins Scientific, GoodRx Holdings, Apollo Medical and COMPASS Pathways” on Apr-29-21.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Squeezing the time span to 30 day period shows us the stock is currently trading -7.23% below one month high and is +4.27% above of the lowest during that time. Looking into the simple moving average, GoodRx Holdings Inc. (GDRX)’s stock stands at a SMA-50 of $40.29 while that of 5-day is reading $40.13.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Moderate Buy by 14 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.30 for the stock.

GoodRx Holdings Inc. Earnings – What Happened With GDRX

Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. GoodRx Holdings Inc. (GDRX) last released financial results for the quarter that ended 12/30/2020, posting a surprise factor of 14.30% for net revenue. During the reported three-month period, company’s sales were $153.54 billion while analysts on average were estimating the same to be $160.58 million.

GDRX – GoodRx Holdings Inc. Stock Earnings Estimates

The perspective of GoodRx Holdings Inc. (NASDAQ:GDRX)’s current quarter earnings identifies that analysts are in consensus over the estimate of 0.07 for stock’s EPS in the current quarter. 13 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was 0.08.

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 397.60 million. GDRX does have institutional investors; and they hold 68.90% of the stock.

GoodRx Holdings Inc. – Insider Activity and Holdings

Moreover, the latest SEC filings also revealed that stock came across 7 new insider purchases involving 389,765 shares. On the other hand, GDRX declared 1,747,252 shares have been sold in 32 insider transactions over the past three months.

As on Dec 30, 2020, Vanguard Group, Inc. (The) was the top most holder in GoodRx Holdings Inc. (NASDAQ:GDRX) with an ownership of 3.45 million shares of the company or 4.98% of the stake worth $139.05 million. The filing also reveals Silver Lake Group, LLC as the second largest holder in the company with a control over 4.37% of the outstanding shares. Its stake is worth $122.24 million for having 3.03 million shares in hand.

Morgan Stanley also came holding a key position in the company during the recent quarter and it now holds 3.90% of the outstanding shares. With this there are now 238 institutions which have possession in GDRX’s shares.

Currently, the stock has been recommended as Moderate Buy by 14 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.30 for the stock.

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by GoodRx Holdings Inc. was 18.24 while posting a debt to equity ratio of 0.94. The count was 97.47 for long-term debt to equity ratio.

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.